During the last session, Zosano Pharma Corporation (NASDAQ:ZSAN)’s traded shares were 2,156,967, with the beta value of the company hitting 3.93. At the end of the trading day, the stock’s price was $1.21, reflecting an intraday loss of -4.72% or -$0.06. The 52-week high for the ZSAN share is $3.06, that puts it down -152.89% from that peak though still a striking +72.89% gain since the share price plummeted to a 52-week low of $0.328. The company’s market capitalization is $128.61 Million, and the average intraday trading volume over the past 10 days was 1.49 Million shares, and the average trade volume was 10.42 Million shares over the past three months.
Zosano Pharma Corporation (ZSAN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.7. ZSAN has a Sell rating from none of the analyst(s) out of 2 analysts who have looked at this stock. Neither of the analyst(s) recommend to Hold the stock while none of them suggest Overweight, and 2 recommend a Buy rating for it. None of the analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.07.
Zosano Pharma Corporation (NASDAQ:ZSAN): Trading Information
Zosano Pharma Corporation (ZSAN) registered a -4.72% downside in the last session and has traded in the green over the past 5 sessions. The stock spiked 6.92% in intraday trading to $1.3 this Tuesday, Apr 06, hitting a weekly high. The stock’s 5-day price performance is 0.83%, and it has moved by 13.08% in 30 days. Based on these gigs, the overall price performance for the year is 129.56%. The short interest in Zosano Pharma Corporation (NASDAQ:ZSAN) is 8.22 Million shares and it means that shorts have 0.79 day(s) to cover.
The consensus price target of analysts on Wall Street is $2.25, which implies an increase of 85.95% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2 and $2.5 respectively. As a result, ZSAN is trading at a discount of 106.61% off the target high and 65.29% off the low.
Zosano Pharma Corporation (ZSAN) projections and forecasts
Statistics show that Zosano Pharma Corporation has underperformed its competitors in share price, compared to the industry in which it operates. Zosano Pharma Corporation (ZSAN) shares have gone up +79.87% during the last six months, with a year-to-date growth rate less than the industry average at -34.69% against 8.4%. Yet analysts are ramping up their growth forecast for the fiscal year 2021. Revenue is predicted to grow 70.8% this quarter and then jump 42.9% in the quarter after that. In the rating firms’ projections, revenue will increase 1739.3% compared to the previous financial year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 60.3%. While earnings are projected to return 78.6% in 2021, the next five years will return 0% per annum.
Zosano Pharma Corporation (NASDAQ:ZSAN)’s Biggest Investors
Zosano Pharma Corporation insiders own 0.7% of total outstanding shares while institutional holders control 13.49%, with the float percentage being 13.58%. Vanguard Group, Inc. (The) is the largest shareholder of the company, while 37 institutions own stock in it. As of Dec 30, 2020, the company held over 3.54 Million shares (or 3.33% of all shares), a total value of $1.87 Million in shares.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The next largest institutional holding, with 2.72 Million shares, is of Aisling Capital Management LP’s that is approximately 2.56% of outstanding shares. At the market price on Dec 30, 2020, these shares were valued at $1.43 Million.
Also, the Mutual Funds coming in first place with the largest holdings of Zosano Pharma Corporation (ZSAN) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Dec 30, 2020 indicates that Vanguard Total Stock Market Index Fund owns about 2,566,514 shares. This amounts to just over 2.41 percent of the company’s overall shares, with a $1.35 Million market value. The same data shows that the other fund manager holds slightly less at 718.82 Thousand, or about 0.68% of the stock, which is worth about $378.89 Thousand.